Tech Company Financing Transactions
ProLacta BioSciences Funding Round
ProLacta BioSciences closed a Series D funding round on 11/3/2011. Investors included Health Evolution Partners.
Transaction Overview
Company Name
Announced On
11/3/2011
Transaction Type
Venture Equity
Amount
Unknown
Round
Series D
Investors
Health Evolution Partners (David Brailer)
Proceeds Purpose
The funding will be used primarily to fund a second facility and to support growth of Prolacta's sales organization.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
1800 Highland Ave.
Duarte, CA 91010
USA
Duarte, CA 91010
USA
Phone
Undisclosed
Website
Email Address
Overview
Prolacta Biosciences, headquartered in Monrovia, California is a life sciences company that provides specialty formulations of human milk for the immunological and nutritional needs of premature and critically ill infants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Elster
Chief Medical Officer
David Rechtman
VP - Operations
Joseph Fournell
VP - Operations
Mark Hannon
VP - R & D
Martin Lee
VP - Regulatory Affairs
Scott Eaker
VP - Sales
Alan Kofsky
Browse more venture capital transactions:
Prev: 11/3/2011: Tangent Medical Technologies venture capital transaction
Next: 11/3/2011: Delivery Agent venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs